Drug Topics

JUNE 12, 2023

A look at how the genetics-based research field can become more fully integrated in all areas of health care going forward.

187

187

Fierce Pharma

JUNE 12, 2023

Two years after the initial COVID-19 vaccine push swept across the globe, Pfizer’s COVID-19 vaccine partner BioNTech is heading to court in its home country of Germany to defend itself against alle | The drugmaker will defend itself against claims from a German healthcare worker who sued the company for at least 150,000 euros ($161,500). The plaintiff alleges she suffered bodily harm resulting from Pfizer and BioNTech's Comirnaty vaccine.

Vaccines 143

Vaccines 143

Drug Topics

JUNE 12, 2023

Over 90% of survey respondents said they believed emergency response simulation training should be required annually.

187

187

Fierce Pharma

JUNE 12, 2023

Bayer recently laid out its ambition | Bayer recently laid out its ambition to achieve $10 billion in sales from its oncology business by 2030 and become a top 10 cancer drug player. To get there, the company is looking outside for a “midsize acquisition,” Bayer’s oncology chief Christine Roth said.

141

141

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

Drug Topics

JUNE 12, 2023

What stood out on Sunday and Monday at the 2023 ASHP Summer Meetings in Baltimore?

187

187

Pharmacy Times

JUNE 12, 2023

Capivasertib combined with fulvestrant doubled progression-free survival in patients with recurrent or progressed advanced stage HR-positive HER2-negative breast cancer compared to placebo.

FDA 123

FDA 123

Pharmacy Times

JUNE 12, 2023

Additionally, data from the SCARLET trial presented at ASCO 2023 indicate the safety and efficacy of sotorasib in combination with platinum-based chemotherapy treating non¬–small cell lung cancer.

Chemotherapy 123

Chemotherapy 123

Fierce Pharma

JUNE 12, 2023

Another biosimilar product copying Johnson & Johnson’s top-selling drug Stelara may enter the U.S. market without a patent infringement challenge by early 2025 thanks to a new settlement. | Following a deal with Amgen, J&J has granted Alvotech and Teva a license to launch their Stelara biosimilar no later than Feb. 21, 2025.

127

127

STAT

JUNE 12, 2023

Brain responses to nutrients in the gut are impaired in people with obesity, and that doesn’t change even after they lose weight through changes in diet, a new study finds, adding to mounting research showing the complexity and persistence of the biological effects of obesity. Using brain imaging, researchers saw that when people without obesity received nutrients, they experienced reduced activity in areas of the brain involved in food intake, suggesting the brain is signaling to them th

124

124

Pharmacy Times

JUNE 12, 2023

Ambulatory care pharmacy residents play a major role in increasing both patient awareness about recommended vaccination and vaccination rates.

Immunization 132

Immunization Vaccines 132

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

FDA

Fierce Healthcare

JUNE 12, 2023

Allina Health System announced last Friday it was placing controversial billing practices on hold as it reevaluates its approach. | Allina reportedly had an explicit policy to cancel outpatient appointments for patients with at least $4,500 in unpaid medical debt. It announced last week it was placing that on hold to reevaluate.

121

121

Fierce Pharma

JUNE 12, 2023

Earlier this year, when Astellas announced that Naoki Okamura was taking over as CEO, the Japanese company said that 2023 was the right time for it to “go on the aggressive to further stimulate gro | Astellas’ new CEO Naoki Okamura didn’t waste any time in carrying out the company’s new mantra to be “aggressive” in its attempts to achieve growth. Less than a month into his tenure, Astellas made its largest acquisition in company history, buying Iveric Bio for $5.9 billion.

110

110

Fierce Healthcare

JUNE 12, 2023

Industry hospital groups are pushing the Centers for Medicare & Medicaid Services to consider a higher annual pay bump and to shed some light on why it believes the number of uninsured patients | Public comments submitted to CMS by the hospital lobby were critical of a "woefully inadequate" 2.8% pay bump, disproportionate share hospital payment calculations, new quality measures and other proposals included in the fiscal year 2024 Inpatient Prospective Payment Systems rule proposal

Hospitals 120

Hospitals 120

Drug Topics

JUNE 12, 2023

Although excessive use can lead to fatigue, alerts can help proactively identify and prevent drug interactions.

112

112

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management Software

Fierce Healthcare

JUNE 12, 2023

Uber's healthcare arm has added grocery and over-the-counter pharmacy product delivery to its growing list of services. | The expansion builds on the company's existing work to rethink the logistics of care—improving patient access and experience while simplifying things on the backend for health plans and providers.

114

114

Drug Topics

JUNE 12, 2023

Study results add to the body of evidence demonstrating the efficacy of CGRP inhibitors for migraine treatment and prophylaxis.

98

98

Fierce Healthcare

JUNE 12, 2023

It has been well established by studies and research that the COVID-19 pandemic exacerbated a growing mental health crisis in the U.S. and around the world. | A recent analysis of the U.S. behavioral health market and massive shifts that have occurred in the past three years point to troubling trends.

110

110

STAT

JUNE 12, 2023

Telehealth company Ro has paused advertising of the obesity drug Wegovy as the drug suffers shortages, a reversal in aggressive promotional efforts by the provider that involved splashy ads in subway stations. Novo Nordisk, the maker of Wegovy, said last month it would limit its starting doses for new patients and pause advertising of the drug to avoid stimulating further demand.

99

99

Fierce Healthcare

JUNE 12, 2023

Prior authorization has been a flashpoint for providers, and, while insurers have taken steps to ease these utilization management protocols, they still play a key role as the industry shifts to va | Prior authorization has been a flashpoint for providers, and, while insurers have taken steps to ease these utilization management protocols, they still play a key role as the industry shifts to value-based care.

Insurance 110

Insurance 110

STAT

JUNE 12, 2023

In February 2022, Diego Miralles, then-CEO of a buzzy new biotech called Laronde, gathered his employees in the company’s shiny new Somerville, Mass., headquarters to relay some unsettling news. An internal investigation had uncovered a “bad assay” and poor note-taking in some of the core research being conducted at the company, Miralles told Laronde’s roughly 130 staffers.

98

98

Fierce Healthcare

JUNE 12, 2023

SimplePractice, an EHR and practice management software company, has launched a subscription service for group practice owners to invest in clinicians’ continuing education. | Group practices that subscribe can offer their clinicians CE as an employee benefit and manage their group CE learning and training.

105

105

The Checkup by Singlecare

JUNE 12, 2023

Avocados are one of the most beloved and consumed superfoods. Also referred to as alligator pear, the avocado fruit is actually a large berry, oval-shaped with green, brown, black, or purplish skin, containing a large seed—and a delicious smooth flesh with a creamy texture when ripe. Avocados are commonly known for being a good source of healthy fats; they can substitute high-saturated-fat foods in your diet, especially if you’re looking to improve cholesterol levels.

Compounding 98

Compounding 98

Fierce Healthcare

JUNE 12, 2023

Healthgrades has collaborated with OutCare Health, a nonprofit focused on LGBTQ+ health equity, to launch a new LGBTQ+ affirming care designation on its site. | The designation identifies providers committed to providing affirming care to the LGBTQ+ community by integrating OutCare’s “OutList,” which is the largest international directory of such providers according to the company.

98

98

STAT

JUNE 12, 2023

Companies, unions, and workers are at a breaking point over how much they pay for health coverage. And some are so exasperated that they’re fighting their own health insurance carriers in court. A string of new lawsuits and judge orders highlights employers’ frustration with health insurers, who they believe are allowing hospitals, doctors, and other entities to charge flagrantly high prices with little to no pushback — knowing that employers and workers will ultimately pick

Insurance 98

Insurance Hospitals 98

Fierce Healthcare

JUNE 12, 2023

The American Cancer Society (ACS) and Color Health, a platform for large-scale care delivery, are teaming up to provide access to convenient and accessible cancer screenings through employers and u | The program includes at-home screenings, care navigation services, care advocacy and educational resources. The partnership will also give employers and unions data on their employee or member screening rates.

98

98

STAT

JUNE 12, 2023

The fight over how doctors should treat transgender children is threatening to tear apart an agreement between U.S. states over divorce laws that has kept the peace for more than a half century. States generally work together to resolve child custody disputes and other issues that arise during divorce, with courts deferring to each other when necessary, according to long-established rules.

98

98

Hospital Pharmacy Europe

JUNE 12, 2023

Integrated care boards (ICBs) have begun offering rotational roles to pharmacists to deploy them across the system to offer greater career development. In a new stocktake report into medicine optimisation , the NHS Confederation highlighted that a shortage of pharmacists and the ‘significant competition between primary care providers and NHS trusts’ in hiring the same professionals.

Hospitals 98

Hospitals 98

Fierce Healthcare

JUNE 12, 2023

Health systems have made big investments in the past few years to build out "digital front doors" for patients. | Health systems have made big investments to build out "digital front doors" for patients. But in many cases, all these "doors" lead down different hallways, resulting in a fragmented, disjointed experience. Artera launched a solution to help solve this pain point by unifying patient messaging.

98

98

Pharmaceutical Technology

JUNE 12, 2023

Lotus Pharmaceuticals and Teraju Pharma have entered a strategic partnership to market Lotus’s products in a range of therapeutic areas in Malaysia. Teraju Pharma will be responsible for marketing and promoting the products using its relationships and infrastructure. The company is a specialised pharmaceutical wholesaler and holds a licence, issued by the country’s ministry of health, to import non-registered pharmaceutical products, orphan drugs and other life-saving medicines.

97

97

Hospital Pharmacy Europe

JUNE 12, 2023

Dystrophic epidermolysis bullosa is caused by a gene mutation, and the recent FDA approval of the corrective gene therapy VYJUVEK represents the first specific treatment to become available. Rod Tucker finds out more. Dystrophic epidermolysis bullosa (DEB) is a rare genetic, blistering skin disorder that is usually present from birth. In addition to blistering, open wounds develop together with extra-cutaneous manifestations, affecting the eyes, oral cavity and many internal organ systems.

FDA 96

FDA Labelling Hospitals 96

Drug Store News

JUNE 12, 2023

HRG reviewed nine products in the health category, 48 in the wellness sector and 32 items in the beauty aisle to see which ones stood out as Products to Watch.

98

98

European Pharmaceutical Review

JUNE 12, 2023

Novo Nordisk intends to invest 15.9 billion Danish kroner (€2.1 billion) to expand an existing active pharmaceutical ingredient (API) production facility in Hillerød, Denmark. The investment, which begins in 2023, will create additional production capacity and increase Novo Nordisk’s ability to meet future market demands. “This important investment will ensure the continuous development of our late-phase pipeline into deliveries of important medicines for treatments to patients worldwide,” state

91

91

Drug Store News

JUNE 12, 2023

According to the settlement agreement, AVT04 (ustekinumab) can be marketed in the United States, subject to regulatory approval, no later than Feb. 21, 2025.

94

94

PharmaVoice

JUNE 12, 2023

Tris Pharma’s CEO is “betting the company” on a pain reliever with the power of an opioid and a lower chance of addiction.

98

98